pirfenidone
-
Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence, 2026, M et al.
Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence Abstract Objective Evaluate safety and efficacy of extended-release pirfenidone (pirfenidone-XR), an anti-inflammatory and anti-fibrotic agent, as an early treatment for...- Chandelier
- Thread
- long covid longitudinal study pirfenidone
- Replies: 0
- Forum: Long Covid research